GE HealthCare Technologies Inc (GEHC) Shares Down Despite Recent Market Volatility

GE HealthCare Technologies Inc (NASDAQ: GEHC) has seen a decline in its stock price by -1.59 in relation to its previous close of 89.53. However, the company has experienced a -0.19% decline in its stock price over the last five trading sessions. Investopedia reported 2024-04-02 that General Electric completed its long-awaited split into three separately traded companies Tuesday, with the company’s energy division GE Vernova making its trading debut under the “GEV” ticker.

Is It Worth Investing in GE HealthCare Technologies Inc (NASDAQ: GEHC) Right Now?

The price-to-earnings ratio for GE HealthCare Technologies Inc (NASDAQ: GEHC) is 29.13x, which is above its average ratio. Moreover, the 36-month beta value for GEHC is 1.21. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The public float for GEHC is 421.28M and currently, short sellers hold a 2.92% of that float. On April 03, 2024, GEHC’s average trading volume was 3.59M shares.

GEHC’s Market Performance

GEHC stock saw a decrease of -0.19% in the past week, with a monthly decline of -4.97% and a quarterly a decrease of 13.95%. The volatility ratio for the week is 1.75%, and the volatility levels for the last 30 days are 1.81% for GE HealthCare Technologies Inc (GEHC). The simple moving average for the last 20 days is -2.99% for GEHC stock, with a simple moving average of 16.64% for the last 200 days.

Analysts’ Opinion of GEHC

Many brokerage firms have already submitted their reports for GEHC stocks, with HSBC Securities repeating the rating for GEHC by listing it as a “Buy.” The predicted price for GEHC in the upcoming period, according to HSBC Securities is $100 based on the research report published on February 15, 2024 of the current year 2024.

UBS, on the other hand, stated in their research note that they expect to see GEHC reach a price target of $88, previously predicting the price at $66. The rating they have provided for GEHC stocks is “Neutral” according to the report published on February 12th, 2024.

Jefferies gave a rating of “Hold” to GEHC, setting the target price at $80 in the report published on November 30th of the previous year.

GEHC Trading at 3.52% from the 50-Day Moving Average

After a stumble in the market that brought GEHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.76% of loss for the given period.

Volatility was left at 1.81%, however, over the last 30 days, the volatility rate increased by 1.75%, as shares sank -4.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +18.89% upper at present.

During the last 5 trading sessions, GEHC fell by -0.19%, which changed the moving average for the period of 200-days by +12.20% in comparison to the 20-day moving average, which settled at $90.60. In addition, GE HealthCare Technologies Inc saw 13.95% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at GEHC starting from O’Neill Kevin Michael, who sale 15,609 shares at the price of $77.32 back on Jul 31 ’23. After this action, O’Neill Kevin Michael now owns 24,025 shares of GE HealthCare Technologies Inc, valued at $1,206,949 using the latest closing price.

Rott Roland, the CEO, Ultrasound of GE HealthCare Technologies Inc, sale 2,473 shares at $77.37 during a trade that took place back on Jun 08 ’23, which means that Rott Roland is holding 22,335 shares at $191,336 based on the most recent closing price.

Stock Fundamentals for GEHC

Current profitability levels for the company are sitting at:

  • 0.12 for the present operating margin
  • 0.41 for the gross margin

The net margin for GE HealthCare Technologies Inc stands at 0.08. The total capital return value is set at 0.1. Equity return is now at value 19.07, with 5.24 for asset returns.

Based on GE HealthCare Technologies Inc (GEHC), the company’s capital structure generated 0.58 points at debt to capital in total, while cash flow to debt ratio is standing at 0.21. The debt to equity ratio resting at 1.38. The interest coverage ratio of the stock is 4.49.

Currently, EBITDA for the company is 3.51 billion with net debt to EBITDA at 2.2. When we switch over and look at the enterprise to sales, we see a ratio of 2.43. The receivables turnover for the company is 4.6for trailing twelve months and the total asset turnover is 0.6. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.00.


To wrap up, the performance of GE HealthCare Technologies Inc (GEHC) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts